- Corporate Officers - C
- Culley Brian M
Insider Trading History of Culley Brian M
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Culley Brian M since 1.
This trader's CIK number is 1310683.
At the time of last reporting, Culley Brian M was the President and CEO of Lineage Cell Therapeutics, Inc.. (stock ticker symbol LCTX).
Also see all insider trading activities at Lineage Cell Therapeutics, Inc..
Note that in the past
Culley Brian M also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Artemis Therapeutics, Inc. (ATMS) by Culley Brian M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | ATMS | 25,000 | $0 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Savara Inc (ANX) by Culley Brian M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | ANX | 34,500 | $20,242 | 0 | $0 | 0 | $0 |
| 2011 | ANX | 0 | $0 | 5,000 | $12,200 | 0 | $0 |
| 2010 | ANX | 5,000 | $9,450 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Lineage Cell Therapeutics, Inc. (LCTX) by Culley Brian M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | LCTX | 0 | $0 | 0 | $0 | 31,249 | $0 |
| 2024 | LCTX | 50,000 | $34,500 | 0 | $0 | 31,249 | $0 |
| 2023 | LCTX | 0 | $0 | 0 | $0 | 31,249 | $0 |
| 2022 | LCTX | 11,650 | $17,036 | 0 | $0 | 46,350 | $0 |
| 2021 | LCTX | 0 | $0 | 0 | $0 | 30,900 | $36,307 |
| 2020 | LCTX | 0 | $0 | 0 | $0 | 61,800 | $67,901 |
| 2019 | LCTX | 10,000 | $10,100 | 0 | $0 | 192,700 | $0 |
| 2019 | LCTX | 0 | $0 | 0 | $0 | 15,450 | $0 |
Insider trading activities at 3 companies by Culley Brian M:
1. Artemis Therapeutics, Inc. (ATMS)
2. Savara Inc (ANX)
3. Lineage Cell Therapeutics, Inc. (LCTX)
Table 1. Insider trading of Artemis Therapeutics, Inc. (ATMS) by Culley Brian M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-10-23 | ATMS | Buy | 25,000 | .00 | 0 |
Table 2. Insider trading of Savara Inc (ANX) by Culley Brian M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-03-14 | ANX | Buy | 20,500 | .59 | 12,095 |
| 2012-03-13 | ANX | Buy | 14,000 | .58 | 8,147 |
| 2011-06-02 | [ANX] | Sale | 5,000 | 2.44 | 12,200 |
| 2010-05-27 | ANX | Buy | 5,000 | 1.89 | 9,450 |
Table 3. Insider trading of Lineage Cell Therapeutics, Inc. (LCTX) by Culley Brian M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-11 | LCTX | Option Ex | 31,249 | .00 | 0 |
| 2024-11-21 | LCTX | Buy | 40,000 | .60 | 24,000 |
| 2024-05-24 | LCTX | Buy | 10,000 | 1.05 | 10,500 |
| 2024-02-11 | LCTX | Option Ex | 31,249 | .00 | 0 |
| 2023-02-11 | LCTX | Option Ex | 31,249 | .00 | 0 |
| 2022-06-30 | LCTX | Option Ex | 15,450 | .00 | 0 |
| 2022-03-31 | LCTX | Option Ex | 15,450 | .00 | 0 |
| 2022-03-31 | LCTX | Buy | 6,400 | 1.53 | 9,792 |
| 2022-03-25 | LCTX | Buy | 5,250 | 1.38 | 7,244 |
| 2021-12-31 | LCTX | Option Ex | 15,450 | .00 | 0 |
| 2021-09-30 | LCTX | Option Ex | 15,450 | .00 | 0 |
| 2021-03-31 | LCTX | Option Ex | 15,450 | 2.35 | 36,307 |
| 2020-12-31 | LCTX | Option Ex | 15,450 | 1.76 | 27,192 |
| 2020-09-30 | LCTX | Option Ex | 15,450 | .94 | 14,476 |
| 2020-06-30 | LCTX | Option Ex | 15,450 | .87 | 13,441 |
| 2020-03-31 | LCTX | Option Ex | 15,450 | .83 | 12,792 |
| 2019-12-31 | LCTX | Option Ex | 15,450 | .00 | 0 |
| 2019-09-30 | LCTX | Option Ex | 15,450 | .00 | 0 |
| 2019-09-17 | LCTX | Option Ex | 61,800 | .00 | 0 |
| 2019-08-13 | LCTX | Buy | 10,000 | 1.01 | 10,100 |
| 2019-01-01 | BTX | Option Ex | 100,000 | .00 | 0 |
| 2019-12-31 | LCTX | Option Ex | 15,450 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Culley Brian M
(President and CEO of Lineage Cell Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.